CNBX Pharmaceuticals Inc (CNBX)
0.0112
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
CNBX Pharmaceuticals Net Income (Quarterly): -0.3255M for Feb. 29, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | -0.3255M |
| November 30, 2023 | -0.1785M |
| August 31, 2023 | -0.5736M |
| May 31, 2023 | -0.1547M |
| February 28, 2023 | -2.624M |
| November 30, 2022 | -0.3577M |
| August 31, 2022 | -1.149M |
| May 31, 2022 | -0.6817M |
| February 28, 2022 | -1.239M |
| November 30, 2021 | -1.323M |
| August 31, 2021 | -0.6812M |
| May 31, 2021 | -1.324M |
| February 28, 2021 | -0.5348M |
| November 30, 2020 | -0.6548M |
| August 31, 2020 | -0.7317M |
| May 31, 2020 | -0.7257M |
| February 29, 2020 | -0.8679M |
| November 30, 2019 | -5.142M |
| August 31, 2019 | -1.393M |
| May 31, 2019 | -0.5474M |
| February 28, 2019 | 3.730M |
| November 30, 2018 | -0.656M |
| August 31, 2018 | -0.7323M |
| May 31, 2018 | -0.8718M |
| February 28, 2018 | -1.635M |
| Date | Value |
|---|---|
| November 30, 2017 | -0.5375M |
| August 31, 2017 | -1.103M |
| May 31, 2017 | -0.2454M |
| February 28, 2017 | -0.4383M |
| November 30, 2016 | -0.147M |
| August 31, 2016 | -0.0685M |
| May 31, 2016 | -0.0265M |
| February 29, 2016 | -0.1469M |
| November 30, 2015 | -0.0553M |
| August 31, 2015 | -0.2049M |
| May 31, 2015 | -0.1538M |
| February 28, 2015 | -0.0553M |
| November 30, 2014 | -0.1277M |
| August 31, 2014 | -0.1686M |
| May 31, 2014 | -0.0559M |
| February 28, 2014 | -0.0322M |
| November 30, 2013 | -0.0133M |
| August 31, 2013 | -0.0319M |
| May 31, 2013 | -0.0047M |
| February 28, 2013 | -0.0046M |
| November 30, 2012 | -0.0151M |
| August 31, 2012 | 0.0144M |
| May 31, 2012 | -0.004M |
| February 29, 2012 | -0.0018M |
| November 30, 2011 | -0.0102M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-5.142M
Minimum
Nov 2019
-0.1547M
Maximum
May 2023
-1.060M
Average
-0.7037M
Median
Net Income (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -3.214M |
| Palatin Technologies Inc | -8.436M |
| iBio Inc | -8.211M |
| Theriva Biologics Inc | -5.165M |
| Oragenics Inc | -12.75M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.0406M |
| Total Expenses (Quarterly) | 0.2471M |
| EPS Diluted (Quarterly) | -0.01 |
| Enterprise Value | 1.604M |
| Gross Profit Margin (Quarterly) | 84.69% |
| Profit Margin (Quarterly) | -800.9% |
| Earnings Yield | -503.3% |
| Normalized Earnings Yield | -338.28 |